MetLife Investment Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Hold |
|
|||||
|
2025
Q1 | $238K | Sell |
|
|||||
|
2024
Q4 | $390K | Buy |
|
|||||
|
2024
Q3 | $500K | Buy |
|
|||||
|
2024
Q2 | $396K | Buy |
|
|||||
|
2024
Q1 | $227K | Hold |
|
|||||
|
2023
Q4 | $136K | Hold |
|
|||||
|
2023
Q3 | $121K | Hold |
|
|||||
|
2023
Q2 | $144K | Sell |
|
|||||
|
2023
Q1 | $168K | Hold |
|
|||||
|
2022
Q4 | $173K | Sell |
|
|||||
|
2022
Q3 | $255K | Buy |
|
|||||
|
2022
Q2 | $197K | Hold |
|
|||||
|
2022
Q1 | $161K | Buy |
|
|||||
|
2021
Q4 | $151K | Hold |
|
|||||
|
2021
Q3 | $221K | Buy |
|
|||||
|
2021
Q2 | $157K | Hold |
|
|||||
|
2021
Q1 | $254K | Buy |
|